Phase II trial of recombinant IFN-α2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancer

Fadlo R. Khuri, Frank V. Fossella, Jin S. Lee, William K. Murphy, Dong M. Shin, Avi B. Markowitz, Bonnie S. Glisson

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of recombinant IFN-α2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences